ClinicalTrials.Veeva

Menu

ESWT vs Conventional Physical Therapy in Greater Trochanteric Pain Syndrome

K

Kanuni Sultan Suleyman Training and Research Hospital

Status

Enrolling

Conditions

Greater Trochanteric Pain Syndrome

Treatments

Device: Extracorporeal Shockwave Therapy (ESWT)
Other: TENS; Hot Pack; Ultrasound

Study type

Interventional

Funder types

Other

Identifiers

NCT07243327
BTAS-ESWT-2025-01

Details and patient eligibility

About

This study aims to compare the effectiveness of Extracorporeal Shockwave Therapy (ESWT) with conventional physical therapy in patients with Greater Trochanteric Pain Syndrome (GTPS). GTPS is a common cause of lateral hip pain, often related to gluteal tendinopathy rather than trochanteric bursitis. Sixty patients will be randomly assigned to two groups: ESWT or conventional physical therapy (TENS, hot pack, ultrasound). Pain (VAS), hip function (Harris Hip Score), lower limb function (LEFS), and global improvement will be evaluated at baseline, week 3, and week 12. The purpose of this study is to determine which treatment provides greater pain relief and functional improvement.

Full description

Greater Trochanteric Pain Syndrome (GTPS) is a frequent cause of lateral hip pain and is now understood to be primarily associated with gluteus medius and minimus tendinopathy rather than inflammation of the trochanteric bursa. Although several conservative treatments are available, including nonsteroidal anti-inflammatory drugs and physical therapy modalities, there is no consensus on the most effective treatment strategy. Extracorporeal Shockwave Therapy (ESWT) has emerged as a potential non-invasive treatment option that may promote tissue regeneration, reduce pain, and improve tendon healing.

This prospective randomized controlled trial will include 60 patients aged 18-65 years with MRI-confirmed GTPS. Participants will be randomly assigned (1:1) to either the ESWT group or the conventional physical therapy group. The ESWT group will receive five sessions over 3 weeks (15 Hz, 3 bar, 2000 pulses). The physical therapy group will receive 10 sessions of TENS (20 minutes), hot pack (20 minutes), and continuous ultrasound (1.5 W/cm², 5 minutes). Both groups will be given a standardized exercise program.

Outcome measures include the Visual Analog Scale (VAS) for pain (night, rest, activity), Harris Hip Score, Lower Extremity Functional Scale (LEFS), and the Global Rating of Change Scale. Assessments will be performed at baseline, week 3, and week 12. The primary objective is to compare the effect of ESWT versus conventional physical therapy on pain reduction. Secondary objectives include evaluating functional improvements and global patient satisfaction.

Enrollment

60 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age between 18 and 65 years
  • Lateral hip pain for at least 3 months
  • Ability to understand study procedures and provide informed consent

Exclusion criteria

  • Hip deformities
  • Gluteus medius, gluteus minimus, or piriformis tendon tears
  • Lumbar radiculopathy or history of lumbar spine surgery
  • Recent trauma or active infection in the hip region
  • Corticosteroid injection to the hip within the last 6 months
  • Neurological, psychiatric, or rheumatologic diseases
  • Active malignancy or systemic inflammatory disease
  • Cognitive impairment preventing cooperation

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

ESWT Group
Experimental group
Description:
Extracorporeal shockwave therapy applied 5 sessions over 3 weeks (15 Hz, 3 bar, 2000 pulses). Standard hip exercises included.
Treatment:
Device: Extracorporeal Shockwave Therapy (ESWT)
Conventional Physical Therapy Group
Active Comparator group
Description:
10 sessions of TENS (20 min), hot pack (20 min), and continuous ultrasound (1.5 W/cm², 5 min). Standard hip exercises included.
Treatment:
Other: TENS; Hot Pack; Ultrasound

Trial contacts and locations

1

Loading...

Central trial contact

Zeynep Karakuzu Güngör, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems